SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

HEAT BIOLOGICS INC (HTBX)

HTBX RSS Feed
Add HTBX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/25/2016 10:46:18 PM - Followers: 73 - Board type: Free - Posts Today: 0
 

Non-Muscle invasive Bladder Cancer ("NMIBC")

Heat Biologics has developed an ImPACT-based treatment for patients with NMIBC.  Similar to HS-110, HS-410 was designed based on knowledge of the various antigens that are known to be shared amongst a high proportion of patients with bladder cancer. Heat is currently conducting a Phase 2 trial using HS-410 for the treatment of NMIBC. This trial is being performed either in combination with the standard of care, BCG therapy, or alone. Heat believes that BCG is likely to synergize with HS-410 due to the activity of BCG to promote trafficking of HS-410 activated cytotoxic T cells into the bladder endothelium. On the other hand, monotherapy HS-410 has significant patient administration advantages by avoiding intravesical delivery, thus evaluation of its single-agent activity is warranted.

For more information please reference study protocol NCT02010203 on clinicaltrials.gov.



About Non-Muscle Invasive Bladder Cancer

In 2015, the American Cancer Society estimated 74,000 new cases of bladder cancer will be diagnosed in the U.S. and an estimated 16,000 deaths will occur. More than 500,000 people in the U.S. have been treated for bladder cancer and 70% of those patients have non-muscle invasive bladder cancer.  Importantly, the U.S. Food and Drug Administration has not approved any new drugs to treat bladder cancer in more than 25 years. Heat's HS-410 represents a viable opportunity to address a significant unmet medical need.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
HTBX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
HTBX News: Heat Biologics Resumes Enrollment in its Non-Small Cell Lung Cancer Trial Evaluating HS-110 in Combination with Anti-PD-1 Che... 09/14/2016 07:00:00 AM
HTBX News: Heat Biologics to Present at Two Upcoming Investor Conferences 09/13/2016 07:00:00 AM
HTBX News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 08/18/2016 08:06:01 AM
HTBX News: Current Report Filing (8-k) 08/18/2016 08:02:00 AM
HTBX News: Current Report Filing (8-k) 08/15/2016 04:30:22 PM
PostSubject
#1060   This week could bring some fun fireworks, chart gallant00 09/25/16 10:46:18 PM
#1059   Will see if we are really into a docoroc2 09/24/16 09:22:38 AM
#1058   Microbiology and Immunology Event: Podack Symposium, Nov 4, Titan V 09/23/16 03:39:03 PM
#1057   Volume usually precedes a share price appreciation. petunia1 09/23/16 01:42:12 PM
#1056   Nope. Rookies think they can force a crash jboatswain 09/22/16 05:18:32 PM
#1055   With 100 -200 Shares go Down.. Its crasy ?? Bonou2 09/22/16 02:36:20 PM
#1054   Keep On Watch List 1.30 Is Coming lv2buygarbage 09/22/16 01:34:59 PM
#1053   What comes..?.. Bonou2 09/22/16 01:15:48 PM
#1052   For now, they do, but not forever. docoroc2 09/22/16 11:21:38 AM
#1051   Sold Time To Find Money lv2buygarbage 09/22/16 10:35:10 AM
#1050   If you are here for the quick buck, docoroc2 09/22/16 10:13:32 AM
#1049   This Dead Money Is Trying My Patience lv2buygarbage 09/22/16 09:53:07 AM
#1048   Perhaps what is now moving at the rate Bonou2 09/22/16 07:02:20 AM
#1047   In coming weeks we will receive 4 sets dia76ca 09/21/16 10:13:43 PM
#1046   The presentation is well worth listening to! The dia76ca 09/21/16 06:32:19 PM
#1045   There is something to hear from the congres..? Bonou2 09/21/16 05:51:10 PM
#1044   Slides are up now. dia76ca 09/21/16 05:16:06 PM
#1043   Its the Conference begining ....?... Bonou2 09/21/16 04:06:38 PM
#1042   This makes you wonder what Heat is worth! dia76ca 09/21/16 12:23:24 PM
#1041   I don't expect much new information. I do dia76ca 09/21/16 11:22:05 AM
#1040   Any thoughts on content of presentation? TIA docoroc2 09/21/16 10:53:00 AM
#1039   Here is the link to the 2016 Aegis dia76ca 09/21/16 10:16:35 AM
#1038   September 21, 2016 • 2:30 pm PT Bonou2 09/21/16 02:33:44 AM
#1037   Agree with you regarding the significance of the forum. Titan V 09/20/16 02:13:50 PM
#1036   Does anyone think Heat would choose to release dia76ca 09/20/16 02:09:52 PM
#1035   Heat Biologics submits updates from phase 1/2 trial Titan V 09/20/16 12:52:20 PM
#1034   Heat will be presenting here in October. Titan V 09/20/16 11:27:08 AM
#1033   My thoughts, as well, but wanted to make docoroc2 09/20/16 09:11:34 AM
#1032   Only 10k shares. Done to ensue panic and Titan V 09/20/16 09:01:15 AM
#1031   Anyone know why the AH destruction? Any news? docoroc2 09/20/16 08:43:18 AM
#1030   Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle Titan V 09/20/16 01:36:32 AM
#1029   Earlier this year, Heat was nominated for two Titan V 09/19/16 01:26:24 PM
#1028   You are correct...the data must continue to be dia76ca 09/18/16 11:24:54 AM
#1027   good post but all depends upon the successful oh_no 09/18/16 09:01:03 AM
#1026   TITAN...you make a good case. Heat has an dia76ca 09/17/16 01:32:18 PM
#1025   $30 a share would be Q4 BO offer Titan V 09/17/16 01:13:37 PM
#1024   "Consensus Ratings for Heat Biologics (NASDAQ:HTBX) dia76ca 09/17/16 11:16:31 AM
#1023   Stalled out here, probably awaiting results. Still a docoroc2 09/17/16 10:10:24 AM
#1022   Roth reiterates BUY rating with $2.75 PT. http://www.marketbeat.com/r/707228 Titan V 09/15/16 01:01:56 PM
#1021   FDA panel knocks back Spectrum’s bladder cancer drug Titan V 09/15/16 10:39:01 AM
#1020   ‘Ideal M.D./Ph.D. Student’ Has Luck on His Side dia76ca 09/14/16 03:06:42 PM
#1019   There is only one kind of war that Titan V 09/14/16 03:00:24 PM
#1018   Great information Titan! There is already strong evidence dia76ca 09/14/16 02:57:08 PM
#1017   In the last update Wolf said big pharma Titan V 09/14/16 02:49:56 PM
#1016   Added some links to the original post... Titan V 09/14/16 02:30:00 PM
#1015   I was researching on bladder cancer too and Titan V 09/14/16 02:18:38 PM
#1014   Today(Sept.14,2016)there was a FDA Oncologic Drugs Advisory Committee dia76ca 09/14/16 01:34:14 PM
#1013   Gp96-Ig/costimulator (OX40L, ICOSL or 4-1BBL) combination vaccine improves Titan V 09/14/16 12:47:51 PM
#1012   HTBX bullish 1.4384 stocktrademan 09/14/16 12:08:54 PM
#1011   They are moving Lung cancer into position to dia76ca 09/14/16 11:14:45 AM
PostSubject